GEN

Summit Therapeutics in up to $5 bln licensing deal for Akeso’s cancer therapy

Dec 6 (Reuters) – Summit Therapeutics Inc (SMMT.O) said on Tuesday it would license China-based Akeso Inc’s (9926.HK) experimental cancer therapy in a deal worth up to $5 billion, sending its shares up 57% in premarket trade. The deal involves an upfront payment of $500 million to Akeso, which will also be eligible for regulatory …

Summit Therapeutics in up to $5 bln licensing deal for Akeso’s cancer therapy Read More »

Wall Street slides in broad-based selloff on recession worries

Meta drops on report of EU concern over targeted ads Indexes down: Dow 0.92%, S&P 1.26%, Nasdaq 1.63% Dec 6 (Reuters) – Wall Street’s main indexes slid on Tuesday, led by declines in Meta Platforms and other technology stocks as investors worried about a longer rate-hike cycle despite warnings of a potential recession next year. …

Wall Street slides in broad-based selloff on recession worries Read More »

Australia sues Telstra for not informing customers of downgrade in internet speed

Dec 6 (Reuters) – Australian competition regulator on Tuesday took the country’s top telecom firm Telstra Corp (TLS.AX) to court for failing to inform some customers about downgrading the upload speed of its broadband plan. The Australian Competition & Consumer Commission (ACCC) initiated the lawsuit in the Federal Court, alleging it downgraded broadband upload speed …

Australia sues Telstra for not informing customers of downgrade in internet speed Read More »

Asia shares bank on eventual China opening; oil earnings

https://tmsnrt.rs/2zpUAr4 China shares push higher, dollar slips More Chinese cities ease coronavirus controls Cap on Russia oil comes into effect, impact uncertain SYDNEY, Dec 5 (Reuters) – Asian shares extended their rally on Monday as investors hoped steps to unwind pandemic restrictions in China would eventually brighten the outlook for global growth and commodity demand, …

Asia shares bank on eventual China opening; oil earnings Read More »

‘We are not your enemy’, say South Korean truckers striking for minimum wage protections

UIWANG, South Korea, Dec 5 (Reuters) – Inside five white tents outside the Uiwang container depot near Seoul, about 200 striking truckers huddle around gas heaters, trying to fight the bitter cold and the government narrative that they are well paid “labour aristocracy .” They are all too aware of the impact their strike has …

‘We are not your enemy’, say South Korean truckers striking for minimum wage protections Read More »

Canada’s deep yield curve inversion adds to BoC rate hike dilemma

TORONTO, Dec 4 (Reuters) – As the Bank of Canada considers ditching oversized interest rate hikes, it is dealing with an economy likely more overheated than previously thought but also the bond market’s clearest signal yet that recession and lower inflation lie ahead. Canada’s central bank says that the economy needs to slow from overheated …

Canada’s deep yield curve inversion adds to BoC rate hike dilemma Read More »

Urals oil discount widens as freight rates for Russian oil jump – traders, Reuters calculations

MOSCOW, Dec 2 (Reuters) – Russian Urals oil’s discount to dated Brent have widened significantly, under pressure from record high freight rates for tankers carrying Russian oil and sending sellers’ revenues well below an agreed EU price cap, two traders said on Friday and Reuters calculations showed. EU governments on Friday agreed to a price …

Urals oil discount widens as freight rates for Russian oil jump – traders, Reuters calculations Read More »

US FDA gives first-ever approval to fecal transplant therapy

Nov 30 (Reuters) – The US health regulator on Wednesday approved Switzerland-based Ferring Pharmaceuticals’ fecal transplant-based therapy to reduce the recurrence of a bacterial infection, making it the first therapy of its kind to be cleared in the United States. The therapy, Rebyota, targets Clostridium difficile, or C. difficile – a superbug responsible for infections …

US FDA gives first-ever approval to fecal transplant therapy Read More »

Mexico, US plan pitch by early 2023 to lure firms from abroad

MEXICO CITY, Dec 2 (Reuters) – Mexican Economy Minister Raquel Buenrostro and US Secretary of Commerce Gina Raimondo on Friday agreed to set out a plan by early 2023 for the relocation of companies from Asia to North America, Mexico’s government said. On her first visit to Washington since taking office in October, Buenrostro has …

Mexico, US plan pitch by early 2023 to lure firms from abroad Read More »

US FDA approves Rigel Pharma’s treatment for a type of leukemia

Dec 1 (Reuters) – Rigel Pharmaceuticals (RIGL.O) said on Thursday the US health regulator has approved its drug for the treatment of patients with a type of leukemia, sending its shares up 14% in extended trading. The Food and Drug Administration approved the drug, which will be sold under the brand Rezlidhia, for the treatment …

US FDA approves Rigel Pharma’s treatment for a type of leukemia Read More »